(Q37903856)

English

Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions

scientific article published on August 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

1 reference

Europe PubMed Central

Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

0 references

1 reference

based on heuristic

inferred from title

1

object named as

Wim Laleman

0 references

object named as

Joost Wauters

4

0 references

Philippe Meersseman

3

0 references

author name string

Len Verbeke

2

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Philippe Meersseman

3

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Jos van Pelt

5

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

David Cassiman

6

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Alexander Wilmer

7

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Chris Verslype

8

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Frederik Nevens

9

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

publication date

1 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Expert Review of Gastroenterology & Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

523-37; quiz 537

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Review article: non-biological liver support in liver failure.

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Acute-on-chronic liver failure: pathophysiological basis of therapeutic options

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Liver cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Trends in mortality after hospital admission for liver cirrhosis in an English population from 1968 to 1999.

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Cirrhosis reversal: a duel between dogma and myth

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Glucoregulation in acute liver failure.

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Model for end-stage liver disease (MELD) and allocation of donor livers

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

New Liver Support Devices in Acute Liver Failure: A Critical Evaluation

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Albumin dialysis: a new therapeutic strategy for intoxication from protein-bound drugs

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Emerging indications for albumin dialysis

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-on-chronic liver failure

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Technology insight: artificial extracorporeal liver support--how does Prometheus compare with MARS?

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Liver failure: basis of benefit of therapy with the molecular adsorbents recirculating system

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Mechanisms of liver damage

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Infection, coagulation, and variceal bleeding in cirrhosis

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Bacterial infections, sepsis, and multiorgan failure in cirrhosis

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

The importance of immune dysfunction in determining outcome in acute liver failure

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Sepsis: a new hypothesis for pathogenesis of the disease process

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

The systemic inflammatory response syndrome in cirrhotic patients: relationship with their in-hospital outcome.

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Tumour necrosis factor-alpha expression by activated monocytes and altered T-cell homeostasis in ascitic alcoholic cirrhosis: amelioration with norfloxacin

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Innate immune dysfunction in acute and chronic liver disease

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Role of neutrophils in acute inflammatory liver injury

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL).

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Non-hepatic insults are common acute precipitants in patients with acute on chronic liver failure (ACLF).

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Bacteremia, acute physiology and chronic health evaluation II and modified end stage liver disease are independent predictors of mortality in critically ill nontransplanted patients with acute on chronic liver failure

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Predictors of mortality and resource utilization in cirrhotic patients admitted to the medical ICU.

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Intensive care unit admissions with cirrhosis: risk-stratifying patient groups and predicting individual survival.

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Predictions and outcomes for the critically ill patient with cirrhosis: is it time to settle on the SOFA and let jaundiced views on outcome MELD away?

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Cirrhotic patients in the medical intensive care unit: early prognosis and long-term survival

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Portal hypertension: from pathophysiology to clinical practice

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Complications of cirrhosis. I. Portal hypertension.

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Postprandial middle cerebral arterial vasoconstriction in cirrhotic patients. A placebo, controlled evaluation.

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Review article: volume expansion in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Hemodynamic effects of albumin dialysis in patients with liver failure: for better or for worse?

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Hemodynamic changes during a single treatment with the molecular adsorbents recirculating system in patients with acute-on-chronic liver failure.

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis.

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Circulatory function and hepatorenal syndrome in cirrhosis.

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Cirrhotic cardiomyopathy: getting to the heart of the matter

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

The hepatoadrenal syndrome: a common yet unrecognized clinical condition

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Adrenal insufficiency in patients with cirrhosis and septic shock: Effect of treatment with hydrocortisone on survival.

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Adrenal insufficiency in liver disease - what is the evidence?

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

The effects of supraphysiological doses of corticosteroids in hypotensive liver failure

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Acute Kidney Injury: New Concepts

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Systemic and Renal Hemodynamics in Oliguric Hepatic Failure: Effect of Volume Expansion*

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

The heart and the liver.

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Hyponatremic and hepatic encephalopathies: similarities, differences and coexistence

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Prognosis and 1-year mortality of intensive care unit patients with severe hepatic encephalopathy.

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study.

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Prometheus--a new extracorporeal system for the treatment of liver failure

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Albumin dialysis: single pass vs. recirculation (MARS).

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Modification of continuous venovenous hemodiafiltration with single-pass albumin dialysate allows for removal of serum bilirubin

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

In vitro comparison of the molecular adsorbent recirculation system (MARS) and single-pass albumin dialysis (SPAD).

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Albumin dialysis in liver failure: comparison of molecular adsorbent recirculating system and single pass albumin dialysis--a retrospective analysis

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Survival improvement in pigs with liver failure and superimposed sepsis by a new liver support system (Hepa Wash®).

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Artificial liver support systems in the management of complications of cirrhosis

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support.

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

The decrease in cytokine concentration during albumin dialysis correlates with the prognosis of patients with acute on chronic liver failure.

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study.

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis.

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: a meta-analysis

1 reference

https://api.crossref.org/works/10.1586%2FEGH.11.47

21 January 2018

Identifiers

10.1586/EGH.11.47

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37903856&oldid=2130881260"